Antibiotic Resistance

Call picture AMR Interventions call 2024.

New projects in the area of AMR interventions

Nov 18, 2024Nov 18, 2024 Anna SundinNews and press

Thirteen projects involving 64 partners from 15 different countries have been recommended for funding within the JPIAMR 17th transnational call: Interventions moving forward to promote action to counteract the emergence and spread of bacterial and fungal resistance and to improve treatments. The call was within the framework of the ERA‐NET JPIAMR-ACTION and the total funding amount is 17,2 M€.

The projects aim to improve, compare and evaluate the effectiveness, cost effectiveness, and uptake of existing interventions against bacterial or fungal infections and/or to design new interventions against fungal infections, by focusing on the two topics of the call:

To design novel or improved interventions to prevent, mitigate and /or treat fungal infections, which are resistant to treatments and/or are at risk of developing resistance.
To improve and/or, compare and/or evaluate strategies, technologies, treatments, methods, protocols or data collection based on existing interventions, aiming to prevent or reduce the emergence or spread of antibacterial or antifungal resistance or to treat/cure infections caused by resistant bacteria/fungi and recommend new policies.

Main achievements of Therapeutics research projects and networks

May 13, 2022Jun 1, 2022 Anna SundinNews and pressLeave a Comment

A report on the outputs, outcome and impact generated by the projects funded in the various JPIAMR transnational research project and network calls under the Therapeutics priority topic has been published.

This report has been prepared using information provided by the coordinators of the research projects and networks in the mid-term and the final term progress reports. The aim is to disseminate information about the outputs and the outcomes of the funded projects and networks to highlight the promising results of the funded research. Some highlights from the report on the main achievements of the Therapeutics research projects and networks and the impact generated are:

The JPIAMR discovery pipeline resulting from the funded research projects has a high level of diversity including direct acting molecules, potentiators or enablers, anti-virulence agents, repurposed agents, phage and nanobiotics.
Six new candidates/leads have been identified and five patents have been filed.
In addition to the peer-reviewed scientific articles in highly-recognised journals, the research projects and networks have also published white papers, roadmaps and position papers that can contribute to evidence-based policymaking.

Download the report: JPIAMR therapeutics discovery pipeline: Outputs, outcomes and impact of the funded projects and networks in the Therapeutics priority topic of the JPIAMR-SRIA (pdf 0,8 MB)

JPIAMR Activity Report 2021

Jan 28, 2022Jan 28, 2022 Anna SundinNews and pressLeave a Comment

The JPIAMR Activity Report that was published today summarises the JPIAMR achievements and major events for the year 2021.

Download the JPIAMR Activity Report 2021 (pdf 2 MB)

JPIAMR awards new projects in the area of transmission and interventions

Nov 18, 2021Nov 18, 2021 Anna SundinNews and pressLeave a Comment

Nineteen projects involving 114 partners from 35 different countries have been recommended for funding within the JPIAMR 13th transnational call One Health interventions to prevent or reduce the development and transmission of antimicrobial resistance. The total funding amount is 25,6 M€.

The call, launched in January 2021, was within the framework of the ERA-NET JPIAMR-ACTION and supported by 30 research funding organisations from 21 countries and by the European Commission. Using a One Health approach, the call aimed to understand the impact of interventions on the development and transmission of antibiotic resistance and to design, implement, evaluate, and compare interventions reducing the development and transmission of antibiotic resistance. Applicants were encouraged to consider the use of interventions that may have an impact in areas where the risk and burden of AMR is greatest, such as in Low and Middle Income countries.

The projects recommended for funding are:

New SAB members appointed

Nov 15, 2021Nov 16, 2021 Anna SundinNews and pressLeave a Comment

JPIAMR is pleased to welcome the nine new Scientific Advisory Board (SAB) members that have been appointed by the JPIAMR Management Board for the period 2022-2024. The new members are:

Ana Alastruey, Instituto de Salud Carlos III, Spain
Uga Dumpis, Pauls Stradiņš University Hospital, Latvia
Sabiha Essack, University of KwaZulu Natal, South Africa
Luca Guardabassi, University of Copenhagen, Denmark
Christian Giske, Karolinska Institute, Sweden
Geetanjali Kapoor, Center for Disease Dynamics, Economics & Policy, India
Joakim Larsson, University of Gothenburg, Sweden
Nilton Lincopan, Universidade de São Paulo, Brazil
Kornelia Smalla, Julius Kühn Institute, Germany

Winners of Hacking AMR 2019

Dec 16, 2019Aug 30, 2021 Anders BjersNews and press, VRI

The grand prize in the Hacking AMR 2019 event that was arranged in Stockholm, Sweden, 13-15 December was won by team ‘Mission Prescription’. The winning project presented an idea to support doctors in their prescribing behaviours by providing them with a tool to monitor their own prescribing in relation to the rest of the medical community. This type of intervention has the goal to reduce incorrect use of antibiotics.

The members in team ‘Mission Prescription’ were, from back row, left to right, in picture above: David Barber, Family Physician and researcher, Queen’s University, Canada; Lennard Epping, PhD student, Robert Koch Institute, Germany; David Hinrichs, Data scientist, Robert Koch Institute, Germany; Sabrina Wong, Health researcher and nurse, Canada; Vendela Wiener, Public Health Agency of Sweden; Sumeet Tiwari, PhD student, Robert Koch Institute, Germany. Missing in picture is Ewan Gray, Researcher, University of Edinburgh, UK.

The People’s choice award and Honourable Mention went to team ‘The Waiting Game’ who developed the concept for a game that can be played while a patient is in a doctor’s waiting room. The goal of the game is to educate the patient on AMR, limiting requests for unnecessary antibiotics.

The aim of the Hacking AMR 2019 hackathon was to bring together scientists, designers, patients, developers, innovators, students and entrepreneurs to collaborate, dream up & create solutions to real-world problems to improve human, animal and environmental health and wellbeing with regards to Antimicrobial Resistance. During the hackathon 40 participants formed seven different teams and worked on diverse digital solutions to AMR.

Hacking AMR 2019 is a Joint Programming Initiative on Antimicrobial Resistance – Virtual Research Institute (JPIAMR-VRI) activity organised by the Swedish Research Council, Institute of Infection and Immunity (III) of the Canadian Institutes of Health Research (CIHR), the Research Council of Norway, Uppsala Antibiotic Center (UAC), and the University of Edinburgh, Edinburgh Medical School. Hacking Health Foundation were consultants for Hacking AMR 2019.

Showreel about the workshop

Design contest for first global Antibiotic Resistance Symbol

Nov 18, 2019Sep 7, 2021 Anders BjersNews and press

A design contest to find the first global Antibiotic Resistance symbol has been launched today by the European Union Joint Action on Antimicrobial Resistance and Healthcare-Associated Infections (EU-JAMRAI). The contest is not about creating another logo, it should be something tangible that can be crafted by anyone and worn by everyone; like the AIDS ribbon. Be a changemaker and take part in the contest or encourage the public to participate!

Read the EU-JAMRAI press release (pdf, opens in a new window)

JPIAMR Highlighted in G20 Health Ministers Joint Declaration

Oct 9, 2018Sep 7, 2021 Anders BjersNews and press

The 2018 G20 Health Ministerial Meeting in Mar del Plata, Argentina, concluded on October 4th with a joint declaration on concrete health policy proposals.

The document considers health a key aspect for sustainable development and calls for a further strengthening health systems. It also recommends concrete actions to address global issues such as antimicrobial resistance, and with commitments for “increasing the level of awareness on the prudent and responsible use and disposal of antibiotics of all healthcare providers, veterinarians, farmers and food producers and of the general public.”

In the declaration, the G20 also mentions JPIAMR together with GARDP, UNITAD, CARB-X and the TB-Alliance, welcoming the work of these leading international initiatives.

Please view the full declaration here.

Coming Soon: Call on Diagnostics and Surveillance

Sep 28, 2018Sep 7, 2021 Anders BjersNews and press

Antimicrobial resistance (AMR) has become one of the major global health and development challenges of the 21st century. The threat of AMR is particularly high in resource-limited and high-risk settings. This is linked to weak human and animal health systems; diverse means of food production, processing and consumption; food safety and food security; water, hygiene and sanitation challenges; and the global movement of people and goods.

In response to these challenges, the JPIAMR will launch a joint transnational call for proposals for innovative research projects on new or improved diagnostics and surveillance strategies, tools, technologies and methods. These research projects should address diagnosis of AMR infections in clinical and veterinary settings, or the emergence, surveillance, and/or detection of AMR in humans, animals and the environment. This Call will support research projects that also have the potential for impact in areas where the risk and burden of AMR is greatest, e.g. in LMIC settings in Asia and Africa. Projects are encouraged to use a One Health approach where relevant. The projected call budget is approx. 20 million Euro.

Scope of the call

Projects should aim to either:

Develop strategies, tools, technologies, and methods for the detection, monitoring, profiling and/or surveillance of antimicrobial resistance and dynamics leading to resistance.
Study ways to facilitate and implement the uptake and use of existing strategies, tools, technologies, and/or methods for the detection, monitoring, profiling and surveillance of antimicrobial resistance and dynamics leading to resistance.

Eligibility

List of participating countries is provisional.
Consortia of eligible scientists from participating JPIAMR member countries and eligible countries in Africa and Asia may apply to this call. Full eligibility criteria will be included in the Call launch. Participating JPIAMR member countries include Canada, Czech Republic, Finland, France, Germany, Israel, Italy, Latvia, Norway, Poland, Romania, Spain and Sweden. Consortia must include a minimum of three and a maximum of six project partners from at least three eligible countries.

The Netherlands has the intention of joining the call but no funding is guaranteed yet. Updates on the progress will be shared.

Expected timeline

November 2018 – Pre-announcement of the call
December 2018 – Publication of the call
February 2019 – Submission deadline for pre-proposal
April 2019 – Full proposal invitations sent to project coordinators
June 2019 – Submission deadline for full proposals
October/November – Final funding decision announced
December 2019/ Early 2020 – Project start

Download as pdf

Fourth JPIAMR Network Call Workshop – report and interviews

May 21, 2018Sep 7, 2021 Anders BjersNews and press

In March researchers gathered in Frankfurt am Main in a final workshop, Maximising Existing and Future Research Efforts and Resource Alignment to Combat AMR, to share some of their activities and findings from research that was supported by funding within the JPIAMR call for networks. Here we present the full workshop report and filmed interviews with some of the funded networks.

The fourth JPIAMR call for networks closed on June 6, 2016. Participating countries in the network call were JPIAMR members: France, Canada, Belgium Spain, the United Kingdom, Germany, Norway, Sweden, and the Netherlands. The coordinators from the countries participating in the call created networks of researchers from many different countries and fields of research.

Major Conclusions

The Network funding mechanism facilitated the formation of successful networks in all strategic JPIAMR areas.
JPIAMR Network funding allowed Networks to carry out a broad range of activities with different outcomes, including white papers/position papers, conferences/workshops, systematic reviews, Standard Operating Procedures, online courses, guidance documents and journal articles, amongst others.

JPIAMR has the One Health approach as an integral part of the Strategic Research Agenda. This is one of the key strengths of JPIAMR and it is reflected in the diversity of the network topics.

The full workshop report can be downloaded here.

About the participating networks

The assembled networks had emphasis on needs at a National and International level to address AMR, within these areas:

Guidelines on use (Human & Veterinary) – Affordable stewardship
Surveillance in primary care
New anti-infective/ New adjuvant therapies / Alternative approaches
Evaluation of risk for generation of resistance in human setting
Rapid diagnostic tests
Role of environmental factors
Infrastructures/Biobanks available relevant to infection and AMR

The networks spanned all of the JPIAMR pillars and were mostly multidisciplinary (spanning at least two pillars). A range of sizes of the networks were represented at the workshop.

Tag: Antibiotic Resistance